Update on the Serum Biomarkers and Genetic Factors Associated with Safety and Efficacy of rt-PA Treatment in Acute Stroke Patients

An accurate understanding of the mechanisms underlying an individual's response to rt-PA treatment is critical to improve stroke patients' management. We thus reviewed the literature in order to identify biochemical and genetic factors that have been associated with safety and efficacy of...

Full description

Saved in:
Bibliographic Details
Main Authors: C. Nafría, I. Fernández-Cadenas, M. Mendioroz, S. Domingues-Montanari, M. Hernández-Guillamón, J. Fernández-Morales, A. del Río-Espínola, D. Giralt, L. Deu, P. Delgado, A. Rosell, J. Montaner
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:Stroke Research and Treatment
Online Access:http://dx.doi.org/10.4061/2011/182783
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849398816274382848
author C. Nafría
I. Fernández-Cadenas
M. Mendioroz
S. Domingues-Montanari
M. Hernández-Guillamón
J. Fernández-Morales
A. del Río-Espínola
D. Giralt
L. Deu
P. Delgado
A. Rosell
J. Montaner
author_facet C. Nafría
I. Fernández-Cadenas
M. Mendioroz
S. Domingues-Montanari
M. Hernández-Guillamón
J. Fernández-Morales
A. del Río-Espínola
D. Giralt
L. Deu
P. Delgado
A. Rosell
J. Montaner
author_sort C. Nafría
collection DOAJ
description An accurate understanding of the mechanisms underlying an individual's response to rt-PA treatment is critical to improve stroke patients' management. We thus reviewed the literature in order to identify biochemical and genetic factors that have been associated with safety and efficacy of rt-PA administration after stroke.
format Article
id doaj-art-9f3f1a6a3d814069a00e21a47ef7aa49
institution Kabale University
issn 2042-0056
language English
publishDate 2011-01-01
publisher Wiley
record_format Article
series Stroke Research and Treatment
spelling doaj-art-9f3f1a6a3d814069a00e21a47ef7aa492025-08-20T03:38:30ZengWileyStroke Research and Treatment2042-00562011-01-01201110.4061/2011/182783182783Update on the Serum Biomarkers and Genetic Factors Associated with Safety and Efficacy of rt-PA Treatment in Acute Stroke PatientsC. Nafría0I. Fernández-Cadenas1M. Mendioroz2S. Domingues-Montanari3M. Hernández-Guillamón4J. Fernández-Morales5A. del Río-Espínola6D. Giralt7L. Deu8P. Delgado9A. Rosell10J. Montaner11Neurovascular Research Laboratory, Neurology and Medicine Departments, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona (VHIR-UAB), 08035 Barcelona, SpainNeurovascular Research Laboratory, Neurology and Medicine Departments, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona (VHIR-UAB), 08035 Barcelona, SpainNeurovascular Research Laboratory, Neurology and Medicine Departments, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona (VHIR-UAB), 08035 Barcelona, SpainNeurovascular Research Laboratory, Neurology and Medicine Departments, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona (VHIR-UAB), 08035 Barcelona, SpainNeurovascular Research Laboratory, Neurology and Medicine Departments, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona (VHIR-UAB), 08035 Barcelona, SpainNeurovascular Research Laboratory, Neurology and Medicine Departments, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona (VHIR-UAB), 08035 Barcelona, SpainNeurovascular Research Laboratory, Neurology and Medicine Departments, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona (VHIR-UAB), 08035 Barcelona, SpainNeurovascular Research Laboratory, Neurology and Medicine Departments, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona (VHIR-UAB), 08035 Barcelona, SpainNeurovascular Research Laboratory, Neurology and Medicine Departments, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona (VHIR-UAB), 08035 Barcelona, SpainNeurovascular Research Laboratory, Neurology and Medicine Departments, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona (VHIR-UAB), 08035 Barcelona, SpainNeurovascular Research Laboratory, Neurology and Medicine Departments, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona (VHIR-UAB), 08035 Barcelona, SpainNeurovascular Research Laboratory, Neurology and Medicine Departments, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona (VHIR-UAB), 08035 Barcelona, SpainAn accurate understanding of the mechanisms underlying an individual's response to rt-PA treatment is critical to improve stroke patients' management. We thus reviewed the literature in order to identify biochemical and genetic factors that have been associated with safety and efficacy of rt-PA administration after stroke.http://dx.doi.org/10.4061/2011/182783
spellingShingle C. Nafría
I. Fernández-Cadenas
M. Mendioroz
S. Domingues-Montanari
M. Hernández-Guillamón
J. Fernández-Morales
A. del Río-Espínola
D. Giralt
L. Deu
P. Delgado
A. Rosell
J. Montaner
Update on the Serum Biomarkers and Genetic Factors Associated with Safety and Efficacy of rt-PA Treatment in Acute Stroke Patients
Stroke Research and Treatment
title Update on the Serum Biomarkers and Genetic Factors Associated with Safety and Efficacy of rt-PA Treatment in Acute Stroke Patients
title_full Update on the Serum Biomarkers and Genetic Factors Associated with Safety and Efficacy of rt-PA Treatment in Acute Stroke Patients
title_fullStr Update on the Serum Biomarkers and Genetic Factors Associated with Safety and Efficacy of rt-PA Treatment in Acute Stroke Patients
title_full_unstemmed Update on the Serum Biomarkers and Genetic Factors Associated with Safety and Efficacy of rt-PA Treatment in Acute Stroke Patients
title_short Update on the Serum Biomarkers and Genetic Factors Associated with Safety and Efficacy of rt-PA Treatment in Acute Stroke Patients
title_sort update on the serum biomarkers and genetic factors associated with safety and efficacy of rt pa treatment in acute stroke patients
url http://dx.doi.org/10.4061/2011/182783
work_keys_str_mv AT cnafria updateontheserumbiomarkersandgeneticfactorsassociatedwithsafetyandefficacyofrtpatreatmentinacutestrokepatients
AT ifernandezcadenas updateontheserumbiomarkersandgeneticfactorsassociatedwithsafetyandefficacyofrtpatreatmentinacutestrokepatients
AT mmendioroz updateontheserumbiomarkersandgeneticfactorsassociatedwithsafetyandefficacyofrtpatreatmentinacutestrokepatients
AT sdominguesmontanari updateontheserumbiomarkersandgeneticfactorsassociatedwithsafetyandefficacyofrtpatreatmentinacutestrokepatients
AT mhernandezguillamon updateontheserumbiomarkersandgeneticfactorsassociatedwithsafetyandefficacyofrtpatreatmentinacutestrokepatients
AT jfernandezmorales updateontheserumbiomarkersandgeneticfactorsassociatedwithsafetyandefficacyofrtpatreatmentinacutestrokepatients
AT adelrioespinola updateontheserumbiomarkersandgeneticfactorsassociatedwithsafetyandefficacyofrtpatreatmentinacutestrokepatients
AT dgiralt updateontheserumbiomarkersandgeneticfactorsassociatedwithsafetyandefficacyofrtpatreatmentinacutestrokepatients
AT ldeu updateontheserumbiomarkersandgeneticfactorsassociatedwithsafetyandefficacyofrtpatreatmentinacutestrokepatients
AT pdelgado updateontheserumbiomarkersandgeneticfactorsassociatedwithsafetyandefficacyofrtpatreatmentinacutestrokepatients
AT arosell updateontheserumbiomarkersandgeneticfactorsassociatedwithsafetyandefficacyofrtpatreatmentinacutestrokepatients
AT jmontaner updateontheserumbiomarkersandgeneticfactorsassociatedwithsafetyandefficacyofrtpatreatmentinacutestrokepatients